• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Good luck to all

Anonymous

Guest
It is going to be a tough week for a lot of us. I don't love it here but this isn't the way I wanted to leave. But this is the life that I chose.

For those of you with one family incomes or little savings and kids at home I hope that you are not severely impacted for too long.

God speed to us all
 

<











Thank you for the kind and thoughful message. It is a sad ending to a job I really enjoyed, most of the time at least. It is very tough to think of being unemployed in this job market. Good luck and best wished to all!!